Chiral alcohols are ubiquitous in organic molecules prepared both naturally and synthetically for a desired biological function. Therefore, development of synthetic methods to access chiral alcohols has been an intense area of research in the field of organic chemistry.^[@ref1]^ One of the most highly studied areas of stereoselective alcohol synthesis is in the controlled addition of an allylmetal reagent to an aldehyde or ketone electrophile.^[@ref2]^ Pioneering work in stereoselective allylation typically employed the generation of a stoichiometric chiral allylmetal nucleophile in a separate step to be used in the allylation reaction with an aldehyde or ketone to generate the chiral alcohol.^[@ref3]^ Over the years, catalytic methods to generate the reactive allylmetal *in situ* from an unreactive allyl source and metal catalyst have emerged.^[@ref4]−[@ref7]^ In particular, reductive coupling strategies^[@ref8]^ that generate the reactive allylmetal from unsaturated hydrocarbons via hydrometalation are extremely powerful, atom-economical approaches for the synthesis of chiral homoallylic alcohols.^[@ref9]^

Recently, an elegant catalytic method for the allylation of ketone and imine electrophiles was developed by Buchwald employing hydrocupration of carbon-substituted allenes (**2**)^[@ref10]^ or 1,3-dienes^[@ref11]^ by a Cu--H catalyst to generate the reactive allylmetal reagent *in situ* ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A). In the ketone version of this process,^[@cit10a]^ the *anti*-diastereomer of the branched product (*anti*-*b*-**3**) was formed as the major product in high diastereo- and enantioselectivity when using chiral bis(phosphine) ligands. However, the linear product *l*-**3** was not formed. Our group became interested in developing a method to generate linear products utilizing this approach, which has not been reported with ketones. While Buchwald demonstrated that both linear and branched products could be obtained when using imine electrophiles^[@cit10c]^ by changing the *N*-substituent on the imine, this is not possible with ketone electrophiles.

![Cu-catalyzed reductive coupling of allenes and ketones.](ol9b02973_0001){#fig1}

Our working mechanistic hypothesis for regio- and diasteroselectivity for this reaction is given in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B. Hydrometalation of allenes typically occurs *trans* to the R′-substituent of the allene due to steric reasons.^[@ref12]^ Therefore, initial hydrocupration of **2** would be expected to afford the *Z*-isomer of the linear (allyl)Cu species *l-Z-***5**. Buchwald has already determined that the turnover-limiting step is allylation of the ketone,^[@cit10a]^ so π--σ--π equilibration of **5** would be expected. Assuming the allylation step proceeds through closed Zimmerman--Traxler^[@ref13],[@ref14]^ chairlike transition states (**6**), the major product obtained in Buchwald's report^[@cit10a]^ (*anti-b-***3**) would be derived from *anti-b-***7** from reaction between *l-E-***5** and **1** via **6c**. The preference for this isomer can be easily rationalized by steric effects. Arguably, *l-E*-**5** would be the least sterically hindered of the three possible (allyl)Cu intermediates (**5**) causing it to be the dominant species in the reaction. Therefore, if this mechanistic hypothesis is correct, then to obtain the linear product (*E-l-***7**), conditions would need to be designed to either stabilize the branched (ally)Cu intermediate *b*-**5** relative to *l*-**5** or make it more reactive.

Our strategy to stabilize (allyl)Cu intermediate *b-***5** is shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C. Use of allene **8** containing a heteroatom tethered ligand should initially generate linear (allyl)Cu species *l-***9** after hydrocupration. The tethered ligand could then help stabilize the branched (allyl)Cu intermediate *b*-**9** through coordination to Cu. Reaction of *b*-**9** with a ketone would then generate linear product *l*-**10** with an enol (X = O) or enamine (X = NR) group representing a masked aldehyde functionality to provide useful chiral γ-hydroxyaldehyde equivalents. Additionally, use of a chiral tethered ligand in allene **8** could enable stereocontrol of the newly formed stereocenter of **10**. Overall, we envisioned that this methodology could be a valuable entry into chiral lactone^[@ref15]^ or tetrahydrofuran^[@ref16]^ containing natural products ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) through lactol **11** obtained by hydrolysis of the enol or enamine functionality of **10**. Herein, we report our findings on the development of a diastereoselective copper-catalyzed reductive coupling of a chiral allenamide with ketones to access the linear isomer (**10**) of product.

![Chiral Lactone and THF Containing Natural Products](ol9b02973_0003){#sch1}

To identify an allene that fit the requirements of **8**, we initially chose to investigate allenamide **14** derived from Evans' auxiliary because it has been synthesized previously ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref17]^ Furthermore, we had hoped that the carbonyl group of the oxazolidinone would serve as a sufficient coordinating group for Cu.^[@ref18]^ Additionally, based on our design in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C, we focused on reaction conditions where Cu would have a low coordination number to facilitate potential coordination of the oxazolidinone carbonyl group (i.e., noncoordinating solvents, monodentate ligands).

###### Copper-Catalyzed Reductive Coupling[a](#t1fn1){ref-type="table-fn"}
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  entry   ligand           TEP[b](#t1fn2){ref-type="table-fn"}   θ[c](#t1fn3){ref-type="table-fn"}   % *l-***15a** (dr)[d](#t1fn4){ref-type="table-fn"}   *l*/*b*[d](#t1fn4){ref-type="table-fn"}
  ------- ---------------- ------------------------------------- ----------------------------------- ---------------------------------------------------- -----------------------------------------
  1       PCy~3~           2056                                  170                                 68 (84:16)                                           80:20
  2       Dcpe             --                                    142                                 14 (84:16)                                           23:77
  3       P(*t*-Bu)~3~     2056                                  182                                 61 (93:7)                                            76:24
  4       P(adam)~3~       2052                                  --                                  71 (93:7)                                            71:29
  5       SPhos            --                                    --                                  7 (68:32)[e](#t1fn5){ref-type="table-fn"}            9:91
  6       XPhos            --                                    --                                  5                                                    12:88
  7       *t*-BuXPhos      --                                    --                                  5                                                    26:74
  8       P(*o*-tol)~3~    2067                                  194                                 14 (81:19)                                           70:30
  9       P(NMe~2~)~3~     2062                                  157                                 79 (87:13)                                           83:17
  10      P(OEt)~3~        2076                                  109                                 90 (83:17)                                           92:8
  11      **16**           --                                    --                                  97 (90:10)                                           97:3
  12      **17**           --                                    --                                  89 (92:8)                                            97:3
  13      P(OPh)~3~        2085                                  128                                 76 (89:11)                                           99:1
  14      P(C~6~F~5~)~3~   2091                                  184                                 12 (85:15)                                           99:1

**1a** (0.25 mmol) and **14** (0.30 mmol) in 0.5 mL of toluene. See the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.orglett.9b02973/suppl_file/ol9b02973_si_001.pdf) for details.

Tolman electronic parameter from ref ([@ref19]).

Ligand cone angle obtained from ref ([@cit19a]).

Determined by ^1^HNMR spectroscopy on the unpurified reaction mixture.

dr of *b*-**15a**.

Trialkyl monodentate phosphines favored the formation of linear product *l*-**15a** with modest *l*/*b* selectivity (entries 1, 3, and 4). Furthermore, use of dcpe, a bidentate ligand commonly employed in Cu--H catalyzed reductive coupling reactions,^[@ref10],[@ref11]^ also gave preferentially the branched product (entry 2). A further survey of monodentate phosphine ligands of varying electronic^[@ref19]^ and steric^[@cit19a]^ properties revealed that the linear selectivity was largely influenced by the electron-donating ability of the ligand employed with less electron-donating ligands affording higher linear selectivities (compare entries 1, 3, 4, and 8--14). There was a rough correlation between ligand cone angle and diasterocontrol with larger ligands affording higher diastereoselectivity (compare entries 1, 3, 4, 9, 10, 12, and 13). Ultimately, phosphoramidite ligand **16** afforded the highest reaction yield with excellent linear selectivity and good diastereoselectivity.

The substrate scope for the linear-selective reductive coupling of ketones and allene **14** is given in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. In general, high linear selectivity was obtained in good to excellent reaction yield for halogenated (*l-***15f,i**), electron-rich (*l*-**15b,c,j,k**), and electron-poor (*l*-**15e,m**) arenes. Hindered ketones bearing *ortho*-substitution on the aryl group required heating to achieve full conversion; however, this did not severely reduce the diastereoselectivity (*l*-**15c**,**h,i**). Additionally, diastereoselectivity and linear selectivity were reduced when the steric bias between the two R-groups of ketone **1** was reduced (*e.g. l*-**15d,l,n,o,p,u**). Notably, a nitrile group was not reduced under the reaction conditions (*l*-**15q**), and both amino (*l*-**15s**) and a free hydroxyl group (*l*-**15k**) was also tolerated.

![Linear Selective Copper(phosphoramidite) Catalyzed Reductive Coupling\
Percent yield represents isolated yield of linear product as a mixture of two diastereomers on 0.5 mmol scale of **1** using 1.2 equiv of **14**; see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.orglett.9b02973/suppl_file/ol9b02973_si_001.pdf) for further details. Diastereomeric ratios (dr) and linear:branched ratios (*l*:*b*) were determined by ^1^H NMR spectroscopy on the unpurified reaction mixture.\
Reaction performed at 60 °C.\
Reaction performed at 40 °C.\
4.0 equiv of Me(MeO)~2~SiH used.](ol9b02973_0004){#sch2}

In regards to factors dictating branched/linear selectivity and stereocontrol in these reactions, studies employing achiral allenamide **18** were informative ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Use of **18** lacking substitution on the oxazolidinone ring afforded reduced linear selectivity in the reaction when the optimized ligand **16** was used. Additionally, use of PCy~3~ in the reaction employing allenamide **18** led to a turnover in the reaction selectivity and favored formation of the branched product *b*-**19**. In contrast, with chiral allenamide **14**, use of PCy~3~ as a ligand afforded linear selectivity ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Based on these observations, and the results of our ligand optimization survey ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), a model to rationalize regio- and stereocontrol in these reactions could be developed ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Mechanistically, hydrocupration of allene **14** or **18** is expected to initially form the *Z*-linear (σ-allyl)Cu complex (*l-Z-***20**; *vide supra*) that will be in equilibrium with the branched (σ-allyl)Cu complex (*b-σ-***20**) through the intermediacy of the (π-allyl)Cu complex *π-***20**. The π-allyl geometry and coordination of the oxazolidinone group to Cu in complex *π-***20** are proposed based on structural information determined by X-ray crystallography and NMR spectroscopy for related anions of this type found in the literature.^[@ref20]^ Considering the turnover-limiting step in Cu-catalyzed reductive coupling of ketones and allenes is believed to be the addition of the (allyl)Cu reagent to the ketone electrophile,^[@ref10]^ this would allow for a pre-equilibrium between *l-Z-***20** and *b-σ-***20** to be established before reaction with the ketone. Therefore, a model to rationalize regioselectivity in the reaction could be developed based on considering the stability of these two intermediates whereby a preference for *l-Z-***20** would result in a branched selective process while preference for *b-σ-***20** in the reaction would result in linear selectivity.^[@ref21]^

![Effect of Oxazolidinone Structure on Regioselectivity](ol9b02973_0005){#sch3}

![Stereo- and Regiochemical model.](ol9b02973_0002){#fig2}

Due to the *Z*-olefin geometry formed in the initial hydrocupration event, reaction regioselectivity could be explained by a competition between the strength of the oxazolidinone coordination versus the size of the A^1,3^-strain present in *l-Z-***20** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The high linear selectivity obtained as the electron-donating ability of the phosphine ligand decreases ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) can be explained by an increase in the preference for complex *b-σ-***20** due to the enhanced electrophilicity at Cu. Additionally, the magnitude of the A^1,3^-strain in *l-Z-***20** would be expected to affect the overall equilibrium between the (allyl)Cu complexes. As a result, when the poorly electron-donating ligand **16** is employed, coordination of the oxazolidinone to the electrophilic Cu atom leads to a preference for *b-σ-***20** leading to linear selectivity when using either allenamide **14** or **18**. A reduction in linear selectivity with ligand **16** when using allenamide **18** in place of **14** can be rationalized by the presence of increased amounts of *l-Z-***20** due to the reduction in the magnitude of the A^1,3^-strain present in *l-Z-***20** when R = H. In contrast, when the electron-rich ligand PCy~3~ is used, the branched product (*b*-**19**) is preferred when the unsubstituted allenamide **18** was used. This may result from a shift in the equilibrium of the (allyl)Cu complexes to favor *l*-*Z*-**20** because of the reduced coordinating ability of the oxazolidinone to the more electron-rich Cu atom. When the magnitude of the A^1,3^-strain present in *l-Z-***20** is increased by utilizing the chiral allenamide **14** with PCy~3~ as ligand, the oxazolidinone coordination is presumably enhanced by destabilizing *l-Z-***20** leading to preferential linear selectivity in the reaction. Furthermore, it is important to point out that if the A^1,3^-strain present in *l*-*Z*-**20** is involved in governing regiochemical control in this reaction, then the alkene moiety in *b-σ-***20** likely remains coordinated to Cu.^[@ref22]^ If the alkene of *b-σ-***20** were to disassociate from Cu, isomerization of the *Z*-alkene to the *E*-isomer *l-E*-**20** could occur that would remove this A^1,3^-interaction that is proposed to be important. Additionally, it is possible that *b-σ*-**20** may not be a discrete intermediate in these reactions, and rather, π-**20** may be the dominant species that reacts directly with ketone **1a** to afford linear product *l*-**15a**/**19**.^[@ref22]^ However, this scenario is also consistent with the model described above for regiocontrol. Finally, the absolute stereochemistry and the *Z*-olefin geometry of the linear product *l*-**15a** can be rationalized by the reaction of *b*-σ-**20** or *π-***20** with ketone **1a** through chair-transition state **21** with the oxazolidinone group in an axial position and complexed with Cu for selective reaction to the *Si*-face of **1a**. Transition state model **21** is supported by literature precedent^[@cit20b],[@cit20c]^ and further supports oxazolidinone coordination in these processes.

Demonstration of the synthetic potential of the reductive coupling products is outlined in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}. Reduction of the oxazolidinone of *l*-**15a** with excess DIBAL afforded lactol **22** after hydrolysis of the resultant eneamine formed in the reduction to unmask the chiral γ-hydroxyaldehyde equivalent. Lactol **22** could then be converted to chiral γ-lactone **23** by oxidation with TPAP/NMO or converted to the 2,5-substituted tetrahydrofuran **24** in good yield albeit with poor diastereocontrol in the Et~2~Zn addition.^[@ref23]^ Finally, the linear selective reductive coupling reaction was performed on a 1.0 g scale to complete a three-step asymmetric synthesis of the natural product (*S*)-(−)-boivinianin A^[@cit15a]−[@cit15c]^ starting from 4′-methylacetophenone.

![Synthetic Applications](ol9b02973_0006){#sch4}

In conclusion, we have disclosed a strategy for the stereoselective reductive coupling of ketones and a chiral allenamide to selectively generate the linear reaction products providing useful chiral γ-hydroxyaldehyde equivalents. This method employs simple starting materials and a readily available catalyst system to furnish chiral products with increased complexity in an efficient manner. Further development of this reaction to enable stereocontrol by a chiral catalyst is currently under investigation and will be reported in due course.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.orglett.9b02973](http://pubs.acs.org/doi/abs/10.1021/acs.orglett.9b02973).Experimental procedures and characterization data for all compounds and NMR spectra ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.orglett.9b02973/suppl_file/ol9b02973_si_001.pdf))
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